Gerald C. Sigua

Gerald Sigua practices at Florida Post Acute Medical Services 1 PA in Clearwater, Florida.

Gerald Sigua's NPI, 1467987461, was assigned on April 27, 2017. Gerald Sigua holds Florida license PAT9110315.

Gerald Sigua's primary practice is Florida Post Acute Medical Services 1 PA, at 1685 Gulf To Bay Blvd, Clearwater, FL 33755 in Pinellas County. The practice phone is (813) 766-4018.

Gerald Sigua's primary practice is Florida Post Acute Medical Services 1 PA in Clearwater, Florida. The medical group on file is TeamHealth. Dmand AI also links Gerald Sigua to 4 more medical groups, 3 group practices and clinics and 2 home health agencies, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Gerald Sigua practices, 5 sites in all. Vendor and product names are available with a free account.

Physician assistant is Gerald Sigua's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Gerald Sigua is licensed in Florida.

Dmand AI lists alcohol use disorders, anxiety, bipolar disorder, depression, drug use disorders, insomnia, non-alzheimer's dementia (chronic) and parkinson's disease among the conditions Gerald Sigua treats.

CMS data shows 1,456 Medicare services from Gerald Sigua across 5 procedure codes in 2024, for 434 Medicare patients. Medicare paid $110,555 for them.

CMS counts 434 Medicare patients who saw Gerald Sigua in 2024. The largest group is 75 to 84, with 139 patients. 75% of them have anxiety, and 75% have arthritis. 58% are also on Medicaid. Their average risk score is 2.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Gerald Sigua's median patient age at 74, with 61% women.

In 2024, Gerald Sigua wrote 6,647 Medicare Part D claims for 283 patients. 98% of them were for generic drugs. CMS names the drug for 6,586 of them, across 45 drugs with 11 or more claims each, at $325,407 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Gerald Sigua for performance year 2024, reported through an alternative payment model (APM). Gerald Sigua accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Gerald Sigua as offering telehealth.

CMS Open Payments shows 34 general payments to Gerald Sigua from 17 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 93% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $270.